Trial Search Results

Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)

This pilot clinical trial studies early brief behavioral intervention in treating sleep disturbance and improving quality of life in patients undergoing bone marrow transplant (BMT). A brief behavioral intervention may reduce symptoms of insomnia and fatigue and improve quality of life and cognitive function in patients undergoing BMT

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Other: quality-of-life assessment
  • Other: questionnaire administration
  • Behavioral: management of therapy complications
  • Behavioral: cognitive assessment
  • Behavioral: educational intervention




Patients proceeding to BMT within the Stanford Adult BMT program will be screened for

Inclusion Criteria:

   - Patient is scheduled to receive bone marrow transplantation.

   - Patient has a diagnosis of Non-Hodgkin's Lymphoma

   - Patient is at least 21 years old

   - Patient is able to understand written and spoken English

   - has preferred sleep phase between 9:00 pm and 3:00 am and a habitual rise time between
   4:00 am and 11:00 am

   - Patient receives a score of 8 or more on the Insomnia Severity Index or takes sleep
   medications 3 times a week

Exclusion criteria:

   - Has an unstable medical or psychiatric illness (Axis I - current or within the last 5

   - Existing cognitive disability

   - Is currently pregnant or nursing

   - Has a history of substance abuse or meets criteria for current alcohol abuse or

   - Has a self-reported history of chronic pre-existing insomnia, sleep apnea or RSL

Ages Eligible for Study

21 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Oxana Palesh